By James Stocklasar Thomas Jr.:Teva (TEVA) has gained the reputation of being a long term player in the oncology field. Which is why the following story means to much to me.Sitting in front of me, a vivacious young woman showed me what looked like the black death of head and neck cancer. I could have wept. Half my age, the angel of death seemed to have penetrated inside her gum line. It sickened me the sight was so repulsive.Head and neck cancer is unforgiving. It attacks the head and neck region including the nasal cavity, lips, sinuses, salivary glands, throat, mouth, and larynx. It disfigures the fortunate people who survive. It leaves people with half a face. Just ask Robert Ebert.Enter Teva. Through key a partnership with a small biotech firm, CEL-Sci (CVM), Teva is helping to advance a product called Multikine to bring hope to the hopeless. Israel-based Teva isComplete Story »